latrepirdine has been researched along with Tauopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksinenko, AY; Bachurin, SO; Buchman, VL; Connor-Robson, N; Kukharsky, MS; Ninkina, N; Peters, OM; Sokolov, VB | 1 |
1 other study(ies) available for latrepirdine and Tauopathies
| Article | Year |
|---|---|
Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice.
Topics: Alzheimer Disease; Animals; Drug Administration Schedule; Indoles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; tau Proteins; Tauopathies | 2013 |